Damora Therapeutics, Inc. (DMRA)

NASDAQ: DMRA · Real-Time Price · USD

28.33

-1.09 (-3.70%)

At close: Jul 29, 2026, 4:00 PM EDT

27.78

-0.55 (-1.94%)

After-hours: Jul 29, 2026, 5:31 PM EDT

Damora Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	532.9	257.62	14.18	21.47	32.79	62.56
Short-Term Investments	-	-	-	11.69	27.44	37.63
Cash & Short-Term Investments	532.9	257.62	14.18	33.15	60.22	100.19
Cash Growth	4363.52%	1717.45%	-57.24%	-44.95%	-39.89%	-38.75%
Other Current Assets	2.51	2.8	2.66	3.62	3.69	9.91
Total Current Assets	535.41	260.42	16.84	36.77	63.91	110.1
Net Property, Plant & Equipment	-	0.1	0.13	0.33	1.17	1.04
Long-Term Investments	-	-	-	-	5.83	9.05
Other Long-Term Assets	0.03	-	0.16	1.13	2.28	2.03
Total Assets	535.44	260.53	17.13	38.23	73.19	122.22

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	12.83	17.67	0.38	1.7	3.35	1.53
Accrued Expenses	6	2.4	0.82	4.13	7.76	3.01
Other Current Liabilities	4.98	-	-	-	-	-
Total Current Liabilities	23.81	20.07	1.2	5.83	11.11	4.54
Long-Term Leases	-	0.05	0.06	0.07	0.33	0.45
Other Long-Term Liabilities	0.03	0.03	0.04	-	-	-
Total Long-Term Liabilities	0.03	0.08	0.1	0.07	0.33	0.45
Total Liabilities	23.84	20.15	1.3	5.9	11.44	4.99

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Preferred Stock	132.45	416.25	1.36	-	-	-
Common Stock	0	-	-	-	-	-
Additional Paid-in Capital	893.54	310.69	291.9	288.04	279.73	273.66
Accumulated Other Comprehensive Income	0.75	0.8	0.1	0.38	-0.24	-0.32
Retained Earnings	-515.15	-487.36	-277.52	-256.09	-217.74	-156.11
Shareholders' Equity	511.6	240.38	15.83	32.33	61.75	117.22
Total Liabilities & Equity	535.44	260.53	17.13	38.23	73.19	122.22

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	0.05	0.06	0.07	0.33	0.45
Net Cash (Debt)	532.9	257.57	14.11	33.09	59.9	99.74
Net Cash Growth	4386.06%	1724.93%	-57.34%	-44.76%	-39.95%	-38.82%
Net Cash Per Share	55.47	188.97	12.20	31.13	58.93	98.71
Book Value	511.6	240.38	15.83	32.33	61.75	117.22
Book Value Per Share	53.25	176.36	13.68	30.42	60.76	116.01
Tangible Book Value	511.6	240.38	15.83	32.33	61.75	117.22
Tangible Book Value Per Share	53.25	176.36	13.68	30.42	60.76	116.01

SEC Filings: 10-K · 10-Q